Taiho Pharma Oceania Pty Ltd

Regulatory activities for this sponsor.

3 result(s) found, displaying 1 to 3

LYTGOBI Taiho Pharma Oceania Pty Ltd

Apr-2024

Prescription medicine evaluation

Active ingredient: futibatinib.
INQOVI 35/100 decitabine 35 mg and cedazuridine 100 mg tablet blister pack (375556)

22 December 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for INQOVI 35/100 decitabine 35 mg and cedazuridine 100 mg tablet blister pack.
INQOVI 35/100 decitabine 35 mg and cedazuridine 100 mg tablet bottle (328904)

2 November 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for INQOVI 35/100 decitabine 35 mg and cedazuridine 100 mg tablet bottle.